763 results on '"Valdés Olmos, Renato"'
Search Results
152. The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
153. Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
154. Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes
155. Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
156. Monitoring tumor response to neoadjuvant chemotherapy using MRI & 18F-FDG PET/CT in breast cancer subtypes
157. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy
158. 99mTc-labelled heat-denatured erythrocyte SPET-CT matching to differentiate accessory spleen from tumour recurrence
159. Advances in radioguided surgery in oncology
160. Evaluation of Dual-Timepoint 18F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar Cancer
161. Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
162. Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes
163. Ganglio centinela en el cáncer pulmonar
164. Sentinel node in lung cancer
165. Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-99mTc-Nanocolloid: A Proof-of-Concept Study in Tongue Cancer Patients Scheduled for Sentinel Node Biopsy.
166. Radiomics in Vulvar Cancer: First Clinical Experience Using18F-FDG PET/CT Images.
167. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy : The RELAPS multicenter randomized trial
168. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial
169. Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
170. Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse
171. Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I–III Breast Cancer: Comparison With Standard PET/CT
172. Hybrid surgical guidance based on the integration of radionuclear and optical technologies
173. Intraoperative 3D Navigation for Single or Multiple 125I-Seed Localization in Breast-Preserving Cancer Surgery
174. Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer
175. Using lymphoscintigraphy as a prognostic tool in patients with cancer
176. Tumor heterogeneity on 18F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib
177. From Incidentaloma to Oncocytoma: A Role for Hybrid Molecular Imaging in Characterising Renal Masses?
178. Effectiveness of an 18F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial
179. A New Portable Hybrid Camera for Fused Optical and Scintigraphic Imaging
180. First clinical experience with a dedicated PET for hanging breast molecular imaging
181. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla
182. Sentinel Node Mapping for Breast Cancer: Current Situation
183. Improved Accuracy and Reproducibility Using a Training Protocol for Freehand-SPECT 3D Mapping in Radio-Guided Surgery
184. The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection
185. Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping?
186. Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green–99mTc-Nanocolloid
187. Abstract P5-01-14: Visualisation of histologic proven breast cancer on the MAMMI-PET: A dedicated PET for hanging breast imaging
188. Abstract P1-02-02: Locoregional assessment by FDG PET/CT in stage II/III breast cancer patients: A multivariate analysis
189. Abstract P1-02-03: The effect on short–term progression free survival of the detection of ≥4 FDG-avid nodes or occult N3–disease in breast cancer patients with PET/CT
190. Optimisation of Fluorescence Guidance During Robot-assisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer
191. Feasibility of Intraoperative Navigation to the Sentinel Node in the Groin Using Preoperatively Acquired Single Photon Emission Computerized Tomography Data: Transferring Functional Imaging to the Operating Room
192. SPECT/CT and sentinel node lymphoscintigraphy
193. Radioguided Surgery of Non-palpable Breast Lesions: Radio Occult Lesion Localization (ROLL).
194. Tracers Applied in Radioguided Surgery.
195. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer
196. Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.
197. Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
198. Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse.
199. Unexpected Lymphatic Drainage of the Treated Breast.
200. Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.